Kestra Private Wealth Services, LLC Mannkind Corp Transaction History

Kestra Private Wealth Services, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$3.34 - $4.29 $6,680 - $8,580	-2,000 Reduced 14.9%	11,423 $41,000
Q1 2023 May 12, 2023	BUY	$3.95 - $5.63 $53,020 - $75,571	13,423 New	13,423 $55,000
Q2 2022 Aug 12, 2022	SELL	$2.67 - $4.77 $6,610 - $11,810	-2,476 Reduced 12.09%	18,003 $69,000
Q1 2022 May 26, 2022	SELL	$2.62 - $4.45 $2,620 - $4,450	-1,000 Reduced 4.66%	20,479 $75,000
Q4 2021 Jan 21, 2022	SELL	$4.05 - $5.37 $52,245 - $69,273	-12,900 Reduced 37.52%	21,479 $93,000
Q3 2021 Oct 21, 2021	BUY	$3.89 - $5.48 $133,734 - $188,396	34,379 New	34,379 $149,000
Q2 2021 Jul 30, 2021	SELL	$3.61 - $5.45 $86,856 - $131,127	-24,060 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$3.14 - $6.14 $19,028 - $37,208	6,060 Added 33.67%	24,060 $94,000
Q4 2020 Jan 21, 2021	BUY	$1.79 - $4.04 $32,220 - $72,720	18,000 New	18,000 $60 Million

243

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Kestra Private Wealth Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Private Wealth Services, LLC with notifications on news.